A multi-disciplinary approach was employed, using a combination of multiomic techniques, including single-cell RNA-sequencing ...

Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventela and Professor ...

A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...

2025年10月17日，翰森制药宣布将旗下CDH17（Cadherin-17）靶向ADC新药HS-20110 授权给罗氏，授予其中国大陆以外地区的独家开发与商业化权利。此项合作交易金额高达15.3亿美元（含8000万美元首付款），成为今年以来中国创新药“出海”最重磅的ADC交易之一。HS-20110 目前正在中美同步进行 Ⅰ期临床，适应症覆盖结直肠癌及其他 CDH17 高表达实体瘤。

NEW DELHI: All hospitals in India should have dedicated teams to counsel families of potential organ and tissue donors, the Centre said in a communication to all states. Hospitals have been asked to ...

本研究针对结直肠癌（CRC）转移过程中分化程度是否保守这一关键问题，通过分析67对匹配的原发灶与转移灶样本，发现组织学分级一致性高达88%。研究证实CDX2、VIL1等结肠分化标志物及上皮-间质转化（EMT）标志物在配对样本中高度一致，表明原发肿瘤的分化 ...